Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-26

FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA granted a supplemental approval for Ondansetron hydrochloride from Eugia US LLC, updating the status of this generic product. The action pertains to a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)